• Home
  • News
  • Coins2Day 500
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
    • Great Place To Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future Of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • Coins2Day 500
    • Coins2Day 500
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
    • Great Place To Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future Of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics

Sy Mukherjee

Sy Mukherjee is a former health care reporter for Coins2Day.

    Page 20 of 100

  • Gates Foundation Mastercard Wellcome coronavirusNewsletters

    A powerhouse trio pledges up to $125 million to fight coronavirus

    By Digital Assets Editor
  • Coronavirus Research WorkHealth

    Gates Foundation, Mastercard, and Wellcome team up to fuel coronavirus drug development

    By Blockchain Reporter
  • Coronavirus fake treatmentsNewsletters

    Beware the coronavirus snake oil salesmen

    By Trading Desk
  • CVS Aetna coronavirus testingNewsletters

    CVS will waive out-of-pocket costs related to coronavirus testing and telemedicine visits

    By Industry Analyst
  • Coronavirus death rateHealth

    What the rising coronavirus death rate really means

    By Contributing Writer
  • CRISPR blindness trialNewsletters

    CRISPR has a milestone moment in treating blindness

    By Staff Writer
  • Coronavirus testNewsletters

    The coronavirus testing conundrum

    By Tech Reporter
  • A researcher works in a lab that is developing testing for the COVID-19 coronavirus at Hackensack Meridian Health Center for Discovery and Innovation on February 28, 2020 in Nutley, New Jersey.Health

    Testing for coronavirus should be free, but it’s not always that simple

    By Market Analyst
  • Amazon Alexa medicationsNewsletters

    Amazon’s Alexa can now give you detailed information on your medications

    By Digital Assets Editor
  • George Scangos coronavirus czar biotechNewsletters

    Pharma vet and former Biogen chief to lead biotech industry’s coronavirus response

    By Senior Editor
  • Biogen Sangamo Alzheimers gene therapyNewsletters

    Biogen is doubling down on Alzheimer’s with a massive gene therapy deal

    By Digital Assets Editor
  • Gilead coronavirus trialNewsletters

    Can Gilead tame the coronavirus?

    By Investment Desk
  • Gilead remdesivir clinical trialsHealth

    Gilead’s coronavirus treatment is barreling its way into new clinical trials

    By Industry Analyst
  • Apple J&J heart studyNewsletters

    Apple and Johnson & Johnson team up on heart study

    By Blockchain Reporter
  • COVID-19-Coronavirus-microscopeHealth

    The first U.S. trial for a coronavirus treatment has started

    By Tech Reporter
    Rankings
    • 100 Best Companies
    • Coins2Day 500
    • Global 500
    • Coins2Day 500 Europe
    • Most Powerful Women
    • Future 50
    • World’s Most Admired Companies
    • See All Rankings
    Sections
    • Finance
    • Leadership
    • Success
    • Tech
    • Asia
    • Europe
    • Environment
    • Coins2Day Crypto
    • Health
    • Retail
    • Lifestyle
    • Politics
    • Newsletters
    • Magazine
    • Features
    • Commentary
    • MPW
    • CEO Initiative
    • Conferences
    • Personal Finance
    • Education
    Customer Support
    • Frequently Asked Questions
    • Customer Service Portal
    • Privacy Policy
    • Terms of Use
    • Single Issues for Purchase
    • International Print
    Commercial Services
    • Advertising
    • Coins2Day Brand Studio
    • Coins2Day Analytics
    • Coins2Day Conferences
    • Business Development
    About Us
    • About Us
    • Editorial Calendar
    • Press Center
    • Work at Coins2Day
    • Diversity and Inclusion
    • Terms and Conditions
    • Site Map

    © 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.